Both vaccines can cause heart inflammation in men, but the benefits outweigh any risks.
The European Medicines Regulator (EMA) has announced a possible link between the very rare heart inflammation and COVID vaccines from Pfizer and Moderna.
However, the regulator stressed that the benefits of vaccinations outweigh any risks.
- Neuroscience Breakthrough: Study Pinpoints Brain Activity That Helps Prevent Us From Getting Lost
- Brief Anger Hampers Blood Vessel Function Leading to Increased Risk of Heart Disease and Stroke – New Study
- New Blood Test Pinpoints Future Stroke Risk – Study Identifies Inflammatory Molecules as Key Biomarker
- Enceladus: A Potential Haven for Extraterrestrial Life in its Hidden Ocean Depths
- New Experiment: Dark Matter Is Not As ‘DARK’ As All We Think
“Diseases such as myocarditis and pericarditis should be included in the side effects list of the two mRNA vaccines,” the EMA’s safety committee said, adding that such cases mostly occur within 14 days of vaccination.
The Committee noted that most of these cases occurred after the second dose of vaccine and in young adult males. Symptoms of the disease include shortness of breath, heart palpitations, and chest pain.
The EMA’s Safety Commission also advised against vaccinating people with a history of the rare blood disorder, capillary leak syndrome, and not vaccinating with Johnson & Johnson’s vaccine.
“The EMA confirms that the benefits of all approved COVID-19 vaccines continue to outweigh the risks,” it said.
It is noted that the EMA has reviewed more than 300 cases of myocarditis and pericarditis in the European Union, Iceland, Norway and Liechtenstein, which are collectively called the European Economic Area (EEA).
Most of the cases were reportedly related to the Pfizer vaccine.
Image by Allen J. Schaben / Los Angeles Times via Getty Images
